Rubicon Research P/B Ratio
Rubicon Research P/B ratio. Rubicon Research (RUBICON) P/B ratio is 19.54 (High), book value per share ₹758.24 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse RUBICON financial statements for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
RUBICON P/B Ratio — Valuation Insights & Book Value Analysis
Rubicon Research price-to-book ratio interpretation, valuation status and historical context — current P/B 19.54 (High). Read RUBICON dividend history for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 19.54, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 839.4% above historical average
- Trading at premium to sector average PB of -0.3
Rubicon Research P/B Ratio Historical Trend
RUBICON annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Rubicon Research share price screener.
RUBICON Historical P/B Ratio — Book Value Per Share & Year-End Price
Rubicon Research annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.27 | ₹758.24 | ₹1722.30 | ₹1,289 | Moderate |
| 2025 | 1.89 | ₹360.67 | ₹680.75 | ₹541 | Moderate |
RUBICON vs Healthcare Peers — P/B Ratio Comparison
Rubicon Research P/B 19.54 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |